dc.contributor.author | Thiongane, Oumy | |
dc.contributor.author | Graham, Janice | |
dc.contributor.author | Broutin, Hélène | |
dc.date.accessioned | 2019-05-21T13:24:20Z | |
dc.date.available | 2019-05-21T13:24:20Z | |
dc.date.issued | 2017-12 | |
dc.identifier.citation | Thiongane, O., Graham, J. E., & Broutin, H. (2017). Lueurs et leurres de la santé globale: À propos de MenAfriVac®, un vaccin « africain » contre la méningite. Anthropologie & développement, 46-47(2017), 213-234 . doi: 10.4000/anthropodev.607 | en_US |
dc.identifier.uri | http://hdl.handle.net/10222/75693 | |
dc.description.abstract | In biomedical narratives, the Meningitis Vaccine Project (MVP) enabled the technology transfer for the development and implementation of MenAfriVac® vaccine at an affordable price for African countries. The presentation of MVP as a success story, however, may be more sociotechnical myth than fact. MenAfriVac® is far from being a silver bullet . While successful in eliminating Meningitis A, MVP rhetoric highlighting meningitis control obscured a more complex epidemiological context. This paper analyzes the discursive construction of success that supports global health single vaccine initiatives. | en_US |
dc.publisher | Open Edition Journals | en_US |
dc.relation.ispartof | Anthropologie & développement | en_US |
dc.title | Lueurs et leurres de la santé globale À propos de MenAfriVac®, un vaccin « africain » contre la méningite | en_US |
dc.type | Text | en_US |